ES417804A1 - Procedimiento para la produccion de composiciones antibac- teriales sinergisticas. - Google Patents

Procedimiento para la produccion de composiciones antibac- teriales sinergisticas.

Info

Publication number
ES417804A1
ES417804A1 ES417804A ES417804A ES417804A1 ES 417804 A1 ES417804 A1 ES 417804A1 ES 417804 A ES417804 A ES 417804A ES 417804 A ES417804 A ES 417804A ES 417804 A1 ES417804 A1 ES 417804A1
Authority
ES
Spain
Prior art keywords
hydrogen
nitro
formula
synergistic
chemotherapeutic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES417804A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES417804A1 publication Critical patent/ES417804A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
ES417804A 1972-08-14 1973-08-11 Procedimiento para la produccion de composiciones antibac- teriales sinergisticas. Expired ES417804A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1200872 1972-08-14

Publications (1)

Publication Number Publication Date
ES417804A1 true ES417804A1 (es) 1976-06-16

Family

ID=4378980

Family Applications (1)

Application Number Title Priority Date Filing Date
ES417804A Expired ES417804A1 (es) 1972-08-14 1973-08-11 Procedimiento para la produccion de composiciones antibac- teriales sinergisticas.

Country Status (10)

Country Link
JP (1) JPS594401B2 (ja)
AT (1) AT347172B (ja)
BE (1) BE803553A (ja)
DD (1) DD109186A5 (ja)
DE (1) DE2340709C2 (ja)
ES (1) ES417804A1 (ja)
FR (1) FR2196157B1 (ja)
GB (1) GB1442625A (ja)
HU (1) HU167371B (ja)
NL (1) NL7311001A (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW7087A1 (en) * 1986-10-03 1988-05-11 Hoffmann La Roche 1,3-disubstituted imidazolium salts
DE3722886A1 (de) * 1987-07-10 1989-01-19 Basf Ag Verfahren zur herstellung von (alpha),ss-substituierten acroleinen und neue substituierte acroleine

Also Published As

Publication number Publication date
HU167371B (ja) 1975-09-27
DE2340709A1 (de) 1974-02-28
GB1442625A (en) 1976-07-14
NL7311001A (ja) 1974-02-18
FR2196157B1 (ja) 1978-07-28
DD109186A5 (ja) 1974-10-20
DE2340709C2 (de) 1983-12-22
BE803553A (fr) 1974-02-13
AT347172B (de) 1978-12-11
JPS594401B2 (ja) 1984-01-30
FR2196157A1 (ja) 1974-03-15
JPS49124062A (ja) 1974-11-27
ATA705973A (de) 1978-04-15
AU5917673A (en) 1975-02-13

Similar Documents

Publication Publication Date Title
ES316768A1 (es) Procedimiento para la preparacion de una nueva poliamida.
ES417804A1 (es) Procedimiento para la produccion de composiciones antibac- teriales sinergisticas.
ES347319A1 (es) Un procedimiento para la preparacion de nuevos compuestos aromaticos heterociclicos.
ES428005A1 (es) Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
ES431526A1 (es) Procedimiento de preparacion de nuevos derivados de la pi- perazina.
ES375443A1 (es) Un procedimiento para la preparacion del compuesto de n-(3,5-dihalofenil) oxazolidina.
ES383467A1 (es) Procedimiento para la preparacion de derivados de pirrol.
ES428600A1 (es) Procedimiento de preparacion de fenilpiperazino-1 amino-3 propanoles-2.
ES307983A1 (es) Procedimiento para la preparacion de nuevas amidas de acido ariloxiacetico.
GB1032253A (en) Coumarin derivatives and process for the production thereof
GB1073976A (en) New biologically active derivatives of pyrrolidine and the manufacture thereof
ES287547A1 (es) Procedimiento para la producción de ácido n-(2,3-dimetilfenil) antranílico y sus sales
ES462843A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos.
ES451084A1 (es) Procedimiento para preparar compuestos monoazoicos.
ES323103A1 (es) Un procedimiento para la preparación de nuevas penicilinas.
ES430840A1 (es) Procedimiento para preparar derivados del acido monoclora- cetamido-7 desacetoxi-3 cefalosporanico.
GB1051328A (ja)
ES363295A1 (es) Un procedimiento para preparar derivados de benzodiacepina.
ES419266A1 (es) Un procedimiento para preparar derivados de quinazolina.
ES395952A1 (es) Un metodo para la produccion de derivados de dihidropirimi-dopiridazina.
ES402410A1 (es) Procedimiento para la obtencion de derivados de quinoxali- na.
ES454098A1 (es) Procedimiento para producir argininamidas y sus sales.
ES397770A1 (es) Un procedimiento para la preparacion de un derivado de n- alqueniltetraciclina.
ES263122A1 (es) Un procedimiento para la fabricación de derivados de 1,4-benzodiazepinas
ES295940A1 (es) Un procedimiento para la preparaciën de compuestos de trifenilohaloetileno